181 related articles for article (PubMed ID: 28422734)
1. Silencing of karyopherin α2 inhibits cell growth and survival in human hepatocellular carcinoma.
Yang Y; Guo J; Hao Y; Wang F; Li F; Shuang S; Wang J
Oncotarget; 2017 May; 8(22):36289-36304. PubMed ID: 28422734
[TBL] [Abstract][Full Text] [Related]
2. KPNA2 promotes renal cell carcinoma proliferation and metastasis via NPM.
Zheng S; Li X; Deng T; Liu R; Bai J; Zuo T; Guo Y; Chen J
J Cell Mol Med; 2021 Oct; 25(19):9255-9267. PubMed ID: 34469024
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
[TBL] [Abstract][Full Text] [Related]
4. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
5. Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
Guo X; Wang Z; Zhang J; Xu Q; Hou G; Yang Y; Dong C; Liu G; Liang C; Liu L; Zhou W; Liu H
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):285-292. PubMed ID: 30883648
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HAGLROS facilitates tumorigenesis and progression in hepatocellular carcinoma by sponging miR-26b-5p to up-regulate karyopherin α2 (KPNA2) and inactivate p53 signaling.
Tang G; Zhao H; Xie Z; Wei S; Chen G
Bioengineered; 2022 Mar; 13(3):7829-7846. PubMed ID: 35291921
[TBL] [Abstract][Full Text] [Related]
7. Novel roles of karyopherin subunit alpha 2 in hepatocellular carcinoma.
Yang X; Wang H; Zhang L; Yao S; Dai J; Wen G; An J; Jin H; Du Q; Hu Y; Zheng L; Chen X; Yi Z; Tuo B
Biomed Pharmacother; 2023 Jul; 163():114792. PubMed ID: 37121148
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.
Hu ZY; Yuan SX; Yang Y; Zhou WP; Jiang H
J Exp Clin Cancer Res; 2014 Jul; 33(1):61. PubMed ID: 25060425
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
[TBL] [Abstract][Full Text] [Related]
10. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.
Zhou J; Dong D; Cheng R; Wang Y; Jiang S; Zhu Y; Fan L; Mao X; Gui Y; Li Z; Li X; Shi B
Oncotarget; 2016 Nov; 7(45):72767-72776. PubMed ID: 27611951
[TBL] [Abstract][Full Text] [Related]
12. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation.
Ma S; Zhao X
Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899
[TBL] [Abstract][Full Text] [Related]
13. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.
Chen T; Liu R; Niu Y; Mo H; Wang H; Lu Y; Wang L; Sun L; Wang Y; Tu K; Liu Q
Cell Death Dis; 2021 Dec; 12(12):1152. PubMed ID: 34903711
[TBL] [Abstract][Full Text] [Related]
14. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
Duan M; Hu F; Li D; Wu S; Peng N
Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma.
Cheng XS; Sun SB; Zhong F; He K; Zhou J
Oncol Res; 2016; 24(4):239-45. PubMed ID: 27656834
[TBL] [Abstract][Full Text] [Related]
16. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma.
Wang W; Jia WD; Hu B; Pan YY
Oncotarget; 2017 Apr; 8(16):26434-26447. PubMed ID: 28460436
[TBL] [Abstract][Full Text] [Related]
17. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0079593 promotes glioma development through regulating KPNA2 expression by sponging miR-499a-5p.
Yang Z; Li C; Fan XY; Liu LJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(3):1288-1301. PubMed ID: 32096160
[TBL] [Abstract][Full Text] [Related]
19. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
[TBL] [Abstract][Full Text] [Related]
20. Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.
Noetzel E; Rose M; Bornemann J; Gajewski M; Knüchel R; Dahl E
Oncogene; 2012 Apr; 31(16):2101-14. PubMed ID: 21909132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
